Results 21 to 30 of about 20,823,742 (292)

In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

Scientific Reports, 2021
Effective and affordable treatments for patients suffering from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are needed.
Yuyong Zhou, Kerry Gilmore, Santseharay Ramirez, Eva Settels, Karen A. Gammeltoft, Long V. Pham, Ulrik Fahnøe, Shan Feng, Anna Offersgaard, Jakob Trimpert, Jens Bukh, Klaus Osterrieder, Judith M. Gottwein, Peter H. Seeberger   +13 more
doaj   +1 more source

SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor

Vaccines, 2021
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has demonstrated the value of pursuing different vaccine strategies. Vaccines based on whole viruses, a widely used vaccine technology, depend on efficient virus production.
Anna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, Rui Costa, Nandini Prabhakar Venkatesan, Xiangliang Lin, Long Van Pham, Shan Feng, Ulrik Fahnøe, Troels Kasper Høyer Scheel, Santseharay Ramirez, Udo Reichl, Jens Bukh, Yvonne Genzel, Judith Margarete Gottwein   +14 more
doaj   +1 more source

Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir

Viruses, 2023
Nirmatrelvir, which targets the SARS-CoV-2 main protease (Mpro), is the first-in-line drug for prevention and treatment of severe COVID-19, and additional Mpro inhibitors are in development.
Karen Anbro Gammeltoft, Yuyong Zhou, Line Abildgaard Ryberg, Long V. Pham, Alekxander Binderup, Carlos Rene Duarte Hernandez, Anna Offersgaard, Ulrik Fahnøe, Günther Herbert Johannes Peters, Santseharay Ramirez, Jens Bukh, Judith Margarete Gottwein   +11 more
doaj   +1 more source

Chronic hepatitis C elimination prison initiative: HCV‐intensive test and treat, a whole prisoner population HCV test‐and‐treat program in England

Health Science Reports, 2023
Background and Aim Prison residents are at high risk for hepatitis C virus (HCV) infection. HCV test‐and‐treat initiatives within prisons provide an opportunity to engage with prison residents and achieve HCV micro‐elimination.
Rachel Halford, Lee Christensen, Sean Cox, Julia Sheehan, Iain Brew, Mark Gillyon‐Powell, Georgia Threadgold, Éamonn O'Moore, Philip J. F. Troke, Andy Jones   +9 more
doaj   +1 more source

Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro

Viruses, 2021
We report the in vitro efficacy of ion-channel inhibitors amantadine, memantine and rimantadine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Yuyong Zhou, Karen A. Gammeltoft, Andrea Galli, Anna Offersgaard, Ulrik Fahnøe, Santseharay Ramirez, Jens Bukh, Judith M. Gottwein   +7 more
doaj   +1 more source

Hepatitis C [PDF]

Annals of Internal Medicine, 1996
To review the virology, epidemiology, pathogenesis, natural history, clinical manifestations, and current treatment of hepatitis C virus (HCV) infection.The MEDLINE database (1966 to 1996) was searched for English-language articles and abstracts on HCV and non-A, non-B hepatitis.
A I, Sharara, C M, Hunt, J D, Hamilton
  +8 more sources

Identification of Novel Determinants of Neutralization Epitope Shielding for Hepatitis C Virus in Vitro

Proceedings, 2020
Epitope shielding is suggested as an important mechanism mediating the escape of hepatitis C virus (HCV) from host-neutralizing antibodies (nAb). [...]
Garazi Peña Alzua, Anne Finne Pihl, Anna Falden Offersgaard, Rodrigo Velázquez-Moctezuma, Elias Honeroed Augestad, Ulrik Fahnøe, Christian Kjaerulff Mathiesen, Mansun Law, Jannick Prentoe, Jens Bukh, Judith Margarete Gottwein   +10 more
doaj   +1 more source

CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020

MMWR Recommendations and Reports, 2020
Summary Hepatitis C virus (HCV) infection is a major source of morbidity and mortality in the United States. HCV is transmitted primarily through parenteral exposures to infectious blood or body fluids that contain blood, most commonly through injection ...
R. Redfield, Maureen A. Leahy, Julia C. Martinroe, Stephen R. Spriggs, Tong Yang, S. Schillie, Carolyn Wester, L. Wesolowski   +7 more
semanticscholar   +1 more source

Screening and Treatment Program to Eliminate Hepatitis C in Egypt.

New England Journal of Medicine, 2020
Screening Program to Eliminate Hepatitis C in Egypt In 2018, the Egyptian government initiated a massive hepatitis C screening and treatment program.
I. Waked, G. Esmat, A. Elsharkawy, M. El-Serafy, W. Abdel-Razek, Reham Ghalab, G. Elshishiney, Aysam Salah, Soad Abdel Megid, K. Kabil, M. El-Sayed, H. Dabbous, Y. El Shazly, Mohamed Abo Sliman, Khalid Abou Hashem, Sayed Abdel Gawad, Nevine M. El Nahas, Ahmed El Sobky, Sahar El Sonbaty, Hamdy El Tabakh, E. Emad, Hany Gemeah, A. Hashem, M. Hassany, N. Hefnawy, Abdel N Hemida, Ayman Khadary, Kamal B. Labib, Faisal Mahmoud, Said Mamoun, T. Marei, S. Mekky, A. Meshref, Alaa Othman, O. Ragab, E. Ramadan, A. Rehan, T. Saad, R. Saeed, M. Sharshar, H. Shawky, M. Shawky, W. Shehata, Hanaa Soror, Mohsen Taha, M. Talha, Adel Tealaab, M. Zein, Alaa Hashish, A. Cordie, Y. Omar, Ehab Kamal, I. Ammar, Mohamed Abdalla, Wafaa El Akel, W. Doss, H. Zaid   +56 more
semanticscholar   +1 more source

Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis

BMC Cancer, 2019
Background Hepatocellular carcinoma (HCC) is the sixth-most common malignancy worldwide. Multiple previous studies have assessed the relationship between TM6SF2 gene polymorphism and the risk of developing HCC, with discrepant conclusions reached.
Shan Tang, Jing Zhang, Ting-Ting Mei, Hai-Qing Guo, Xin-Huan Wei, Wen-Yan Zhang, Ya-Li Liu, Shan Liang, Zuo-Peng Fan, Li-Xia Ma, Wei Lin, Yi-Rong Liu, Li-Xia Qiu, Hai-Bin Yu   +13 more
doaj   +1 more source